Researchers Find Colorectal Cancer Cases Are Higher in

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
348
Researchers Find Colorectal Cancer Cases Are Higher in Minorities

Marvella Ford and Kristin Wallace are among researchers who have studied colorectal cancer disparities and rates. These researchers are becoming increasingly concerned as more young individuals are diagnosed with this cancer. Wallace recently published a study that looked at genetic markers which could explain the disparities in outcomes and diagnoses between whites and African Americans earlier in the year.

The study, which was published in “Frontiers in Oncology,” found that in comparison with whites, African Americans had a lower prevalence of rectal noncancerous tumors and were generally more susceptible to noncancerous tumors. The study also found that these lesions had higher chances of possessing immunosuppressive signatures, which suggested a compromised immune system response to the disease.

Previous studies have discovered that these differences were especially pronounced in younger patients, noting that researchers needed to focus on why there was a difference in survival in younger Caucasian patients vs. in young African Americans below age 50.

A study published last year in “Clinical and Translational Gastroenterology” also identified various counties in South Carolina as hot spots for this type of cancer.

Ford is interested in the socioeconomic, geographical and behavioral factors that could be causing younger individuals, particularly African Americans in South Carolina, to succumb to colorectal cancer. Researchers are also concerned about why some populations have worse outcomes than others. A 2019 study that Wallace was a part of found that while rectal cancer among Caucasians saw the highest increase, the rates of survival for all early-onset colorectal cancer improved except for young African Americans who had been diagnosed with proximal colon cancer.

Wallace explained that the disparities may be partly attributed to genetics and ancestry, noting that behavioral and lifestyle factors such as stress, smoking, diabetes and obesity likely played a bigger role. While more research is needed to discover the cause of the increase in colorectal cancer cases, clinicians and the CDC recommend regular screening begin at age 45, as early diagnosis and beginning treatment early has a much better outcome for the patients as well as a higher survival rate.

At the moment, no effective therapy exists for advanced-stage colorectal cancer. If the disease is caught in stage 1 or 2, the survival rate is 90%. However, advanced cases that are diagnosed and begin treatment later only have a 10% average survival rate.

Individuals with inflammatory bowel disease, a family history of colorectal cancer or genetic syndromes are advised to get screened more frequently — and earlier. With companies such as AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) specializing in bringing cutting-edge innovations to the cancer-screening segment, early cancer diagnostic technology could soon be readily available to all who need those services.

NOTE TO INVESTORS: The latest news and updates relating to AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) are available in the company’s newsroom at https://ibn.fm/ANPC

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer


AnPac Bio-Medical Science Co. Ltd. (ANPC) Stock Research Links

ANPC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 278

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 744

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 481

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 74

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Anthropic Bears Get New Tools, But Daily Risk Bites

Updated Category News Views 72

A $81.3 Billion Offering Invites Fast Money Anthropic arrived in public markets with the sort of numbers that make traders reach for both a calculator and a helmet. The company priced 980 million Class A shares at $83 on November 18, 2026, raising roughly $81.3 billion, then opened at $111.50 when it began Nasdaq trading on November 19. That is a monster debut by any...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 181

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 473

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
EyePoint Lawsuit Puts DURAVYU Claims Under a Microscope

Updated Category News Views 107

Nothing makes biotech investors reach for the aspirin faster than a lawsuit centered on whether a drug worked as advertised. EyePoint, Inc. is facing a proposed federal securities class action alleging that the company overstated the effectiveness of DURAVYU and, by extension, its clinical, regulatory, and commercial prospects. That is a serious allegation, but it remains...

Continue Reading
DKSH's Vietnam Oncology Pact Carries Real Promise, Risk

Updated Category News Views 102

A cancer-market announcement ought to make investors pause before they reach for a spreadsheet. Specialised Therapeutics and DKSH have signed an exclusive partnership to bring oncology therapies into Vietnam, and the human case is painfully clear: the country recorded an estimated 180,000 new cancer cases and more than 120,000 deaths annually in the 2022 GLOBOCAN data....

Continue Reading
Luca's Campo Morado Denial Makes Guerrero Risk Clear

Updated Category News Views 94

A Dangerous Headline Needs More Than a Quick Rebuttal One ugly allegation can do more damage to a junior miner than a lousy quarter, especially when it involves a mine in Guerrero State and alleged criminal control. Luca Mining has flatly rejected Mexican media reports claiming that its Campo Morado Mine is controlled by a criminal organization. The company says the...

Continue Reading

Top 5 Most Recently Viewed Articles

Surge in Holiday Online Spending Driven by Mobile Shopping Trends

Updated Category News Views 145

The Rise of Mobile Shopping in the Holiday Season The 2024 holiday season has presented remarkable insights into consumer behavior, showcasing a notable 9% increase in online spending throughout the United States. This year's shopping frenzy, spanning from early November to the end of December, has seen consumers gravitate towards mobile devices for their purchases,...

Continue Reading
How Trump’s Tariffs Affect Your Daily Coffee Experience

Updated Category News Views 353

Exploring the Impact of Tariffs on Coffee Prices Recently, Sen. Elizabeth Warren (D-Mass.) criticized President Donald Trump during National Coffee Day, drawing attention to the rising costs of coffee that have resulted from his contentious tariff policies. While Trump expressed festive wishes associated with the day, Warren pointed out that these tariffs have caused...

Continue Reading
Replenish Nutrients: SRC Invests $15M, Aims for 5x Capacity

Updated Category News Views 49

Replenish Nutrients Aims to Change the Game When a $15 million investment surfaces in the world of regenerative agriculture, you know someone means business. SRC Agrominerals throwing cash at Replenish Nutrients could shake things up big time. Imagine an investment poised to bump Replenish's owned capacity by fivefold. It's not pocket change; it's laying down tracks for...

Continue Reading
Investing Opportunities Amid Securities Class Actions for 2025

Updated Category News Views 113

Understanding the Recent Class Action Lawsuits Law Offices of Howard G. Smith has alerted investors about ongoing class action lawsuits for several companies including Lantheus Holdings, Inc. (NASDAQ: LNTH), VF Corporation (NYSE: VFC), Fluor Corporation (NYSE: FLR), and Cytokinetics, Incorporated (NASDAQ: CYTK). Each case presents a unique opportunity for shareholders to...

Continue Reading
Silanes Market Projected to Reach $5.20 Billion by 2029

Updated Category News Views 77

Growth of the Silanes Market Towards 2029 The silanes market has been observed to be on a significant growth trajectory, with forecasts predicting an increase from USD 3.62 billion in 2024 to USD 5.20 billion by 2029. This remarkable rise is associated with a compound annual growth rate (CAGR) of 7.5% over the coming years. The driving force behind this expansion can be...

Continue Reading